You Have Traction. But Do You Have a U.S. Strategy?
- Esra Talu

- 10 hours ago
- 5 min read
What we keep seeing across international founders preparing for U.S. expansion — and why the post-pandemic playbook has changed.

Founders often come to us at a very interesting moment.
They are not at the idea stage anymore. They have built something. They have customers, products, early revenue, partnerships, retail presence, marketplace listings, or accelerator recognition. They may already have traction in their home market. Some may even have taken their first step into the U.S. through Amazon, a Delaware company, a trade show, a buyer conversation, or an investor introduction.
On paper, it looks like progress.
And often, it is.
But traction is not the same as strategy.
This is one of the most important lessons we see repeatedly at GoGlobal, across very different sectors — from consumer products and food brands to SaaS startups, marketplaces, fintech, healthtech, creative platforms, and tech-enabled businesses.
A founder may have momentum. A product may have potential. A market may look attractive. But the real question is different:
Do you have a U.S. strategy?
Not a dream. Not a pitch line. Not a generic “we are entering the U.S.” statement. A real strategy.
One that explains where the product belongs, who the buyer is, what proof already exists, which channel should come first, what the unit economics look like, how much capital is actually needed, and what must be true before the company can scale.
The U.S. Is Not Just Another Market
For many international founders, the U.S. represents the ultimate growth opportunity. It is large, visible, capital-rich, competitive, and often seen as the market that validates global potential.
But the U.S. is not simply another market to enter.
It is a readiness test.
It tests your positioning. It tests your pricing. It tests your margins. It tests your operations. It tests your founder narrative. It tests your ability to sell, repeat, adapt, and survive pressure.
For a consumer brand, the test may appear through packaging, shelf velocity, Amazon reviews, distributor margins, retail buyer expectations, and customer repeat purchase.
For a SaaS startup, it may appear through ICP clarity, sales cycles, pricing models, enterprise readiness, data security expectations, and investor storytelling.
For a marketplace, it may appear through supply-demand balance, trust, liquidity, acquisition costs, and local market behavior.
Different sectors, same pattern.
The U.S. does not reward vague ambition. It rewards evidence.
Being Available in the U.S. Is Not the Same as Being Ready for the U.S.
One of the most common mistakes we see is confusing access with readiness.
Launching on Amazon is access. Incorporating in the U.S. is access. Attending a trade show is access. Getting a few investor meetings is access. Being introduced to a distributor is access.
All of these can be useful. But none of them, alone, is a strategy.
Amazon, for example, can be a powerful testing channel for a consumer brand. It can help measure demand, pricing sensitivity, customer feedback, conversion, packaging response, and repeat purchase. But Amazon is not, by itself, a U.S. market-entry strategy.
Retail is not just shelf space.Distribution is not just logistics.Fundraising is not just a number.And global expansion is not just ambition.
The real work begins when a founder asks:
What exactly are we testing? Which channel should come first? What proof do we need before raising capital? What should we not spend money on yet? What would make this opportunity investor-ready, buyer-ready, and operationally realistic?
These are not theoretical questions. They are the questions that prevent expensive mistakes.
The U.S. Playbook Has Changed
My perspective on market entry did not begin in a boardroom. It began in the 1990s, building during one of the earliest waves of e-commerce in Türkiye, long before “startup ecosystem” became a familiar term.
Since then, we have lived through several versions of the global market cycle: the rise of digital commerce, the acceleration of platforms, the expansion of venture capital, the pandemic reset, supply-chain disruptions, capital market corrections, inflationary pressure, geopolitical tension, and today’s more selective investment environment.
Each cycle changed how companies expand.
The post-pandemic U.S. market is especially unforgiving to unclear strategy. Buyers are more disciplined. Investors are more selective. Consumers are more value-conscious. Capital is more cautious. Distribution is more expensive. Growth expectations are more evidence-based.
In this environment, enthusiasm is not enough.
Founders need timing.They need sequencing.They need proof.They need a realistic understanding of cost.And they need to know what kind of traction actually matters for the market they are entering.
The old playbook of “enter first, figure it out later” has become much more expensive.
Small Budgets Need Sharp Strategy
We often see founders trying to enter the U.S. with limited capital. This is not necessarily a problem.
A small budget can be useful — if it has a very precise purpose.
It can fund a validation sprint. It can clean up compliance and positioning. It can test Amazon performance. It can support buyer sampling. It can help refine a pitch, pricing model, or go-to-market sequence. It can create the first layer of U.S. market proof.
But a small budget cannot carry an undefined ambition.
The issue is not whether a number is too little or too much. The issue is whether the use of funds matches the ambition.
If the goal is to “scale across the U.S.,” the budget, team, channel strategy, inventory, marketing, and partnerships must reflect that. If the goal is to validate the market and collect data before a larger raise, then the plan should say that clearly.
Investors understand realism. Buyers understand preparation. Markets understand discipline.
What they do not reward is a gap between ambition and execution.
Momentum Needs Sequencing
At GoGlobal, we often meet founders after momentum, but before clarity.
That is a very important stage.
Because momentum creates energy, but it can also create noise. Founders receive advice from many directions. Enter this market. Talk to this distributor. Raise this amount. Change the packaging. Open a U.S. company. Go to retail. Focus on Amazon. Focus on investors. Focus on partnerships.
All may sound reasonable.
But the question is: in what order?
For most international founders, the right sequence matters as much as the right opportunity.
A consumer brand may need Amazon data before approaching certain retail buyers. A SaaS company may need U.S. ICP validation before investor outreach.
A marketplace may need one focused city or vertical before expanding nationally.
A tech-enabled product may need a stronger financial model before fundraising conversations.
Strategy is not just deciding what to do. It is deciding what not to do yet.
The Real Question
The question is not simply:
“Can we enter the U.S.?”
Most companies can enter in some form.
The better question is:
What must be true for us to compete, grow, and raise capital in the U.S. market?
That question changes the conversation.
It moves the founder from excitement to evidence. From visibility to readiness. From access to strategy. From ambition to execution.
And in today’s market, that shift matters.
The U.S. remains one of the most powerful markets in the world for founders. But it is also one of the most demanding. It rewards preparation. It rewards clarity. It rewards founders who understand not only why they want to enter — but how, when, with whom, and at what cost.
At GoGlobal, this is the work we do with international founders: helping them turn momentum into market strategy, and ambition into executable growth.
Because traction is valuable.
But without a strategy, traction can be misunderstood, mispriced, or lost.
And in the U.S. market, being promising is not enough.
You have to be ready.




Comments